New hope for tough stomach cancers: first human trial begins
Disease control
Recruiting now
This early-stage study is testing a new drug called BDC-4182 for people with advanced stomach or esophageal cancer that has spread or can't be removed by surgery. The main goals are to find the safest dose and see how well the body handles the drug. Researchers will also check if…
Phase: PHASE1, PHASE2 • Sponsor: Bolt Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC